Insider Selling: Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Insider Sells $1,404,000.00 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) insider Helen Louise Collins sold 40,000 shares of the stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $35.10, for a total transaction of $1,404,000.00. Following the completion of the sale, the insider directly owned 25,000 shares in the company, valued at approximately $877,500. The trade was a 61.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Helen Louise Collins also recently made the following trade(s):

• On Tuesday, March 17th, Helen Louise Collins sold 5,000 shares of Bitwise MARA Option Income Strategy ETF stock. The stock was sold at an average price of $27.76, for a total transaction of $138,800.00.

Bitwise MARA Option Income Strategy ETF Price Performance

Shares of NYSEARCA IMRA opened at $12.27 on Tuesday. Bitwise MARA Option Income Strategy ETF has a 12-month low of $11.99 and a 12-month high of $60.73. The company has a market capitalization of $2.94 million, a PE ratio of 245.40 and a beta of -6.67. The firm’s 50-day moving average is $14.30 and its two-hundred day moving average is $22.21.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.